| Bioactivity | Anselamimab (CAEL-101) a humanized IgG1-κ anti-Amyloid fibrils antibody targeting to serum amyloid A1 (SAA1)[1][2]. |
| Target | Serum amyloid A1 (SAA1) |
| Name | Anselamimab |
| CAS | 2414866-63-8 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Palladini G, et al. How I treat AL amyloidosis. Blood. 2022 May 12;139(19):2918-2930. [2]. Anselamimab. IMGT/mAb-DB. |